title: A phase II study of dasatinib followed by imatinib in newly diagnosed, previously untreated patients with chronic phase CML Kinase Inhibition with Sprycel Start‐up Cancer type: Chronic Myeloid Leukaemia Status: Open to recruitment (Auckland & Dunedin) Brief description:   The KISS Study is a multicentre, open label, prospective, non-randomised study of treatment modification in … Continue reading KISS